ARSA and metachromatic leukodystrophy: One of the key therapies for MLD is Libmeldy (atidarsagene autotemcel)—an ex vivo gene therapy based on autologous CD34+ hematopoietic stem cells (HSCs) transduced with a lentiviral vector encoding the ARSA gene (LV-ARSA) [77].